Summary & Overview
CPT 81436: Genetic Testing Procedure
CPT code 81436 represents a genetic testing procedure commonly performed in laboratory settings to support the diagnosis and management of various hereditary and neoplastic conditions. This code is scheduled for deletion on December 31, 2024, marking a notable shift in the coding landscape for genetic testing services. Nationally, genetic testing is a rapidly evolving field, and changes in CPT codes can impact billing practices, payer coverage, and clinical workflows.
Key payers covered in this analysis include Blue Cross Blue Shield, Cigna Health, and UnitedHealthcare. The publication provides an overview of the clinical context for CPT 81436, including its typical use cases, associated diagnoses, and relevant modifiers. Readers will gain insight into policy updates, coding changes, and payer coverage trends related to genetic testing. The summary also highlights the importance of understanding the implications of code deletions and updates for laboratories, clinicians, and billing professionals.
This article is designed to inform stakeholders about the national significance of CPT 81436, offering benchmarks and policy perspectives that are relevant across the healthcare industry. The content is organized to provide clear, concise information on the code's clinical applications, payer coverage, and upcoming changes, ensuring readers are prepared for the evolving landscape of genetic testing billing.
CPT Code Overview
CPT 81436 is a code used for genetic testing services, typically performed in a laboratory setting (POS 81). This code has been marked for deletion effective December 31, 2024. Genetic testing plays a critical role in identifying hereditary conditions and informing clinical decision-making. Laboratories specializing in medical genetics utilize this code to bill for advanced genetic analyses that support patient diagnosis and management. The deletion of CPT 81436 signals a significant change in coding practices for genetic testing services.
Clinical & Coding Specifications
Clinical Context
A patient presents with a personal or family history suggestive of hereditary cancer syndromes, such as colorectal or endometrial cancer. The ordering physician, typically a specialist in medical genetics, requests comprehensive genetic testing to identify potential pathogenic variants associated with these malignancies. The procedure is performed in a laboratory setting (Place of Service 81), where advanced molecular techniques are used to analyze the patient's DNA. The results inform clinical management, including risk assessment and potential targeted therapies.
Coding Specifications
-
Modifier
26: Used to indicate the professional component of the service, such as interpretation of genetic test results by a qualified provider. -
Modifier
59: Used to denote a distinct procedural service, indicating that the genetic test is separate from other procedures performed on the same day.
| Modifier Code | Description |
|---|---|
26 | Professional Component |